Médicaments de l’inflammation

D. Muster (Professeur associé, stomatologiste attaché consultant, pharmacien, docteur ès sciences physiques)
{"title":"Médicaments de l’inflammation","authors":"D. Muster (Professeur associé, stomatologiste attaché consultant, pharmacien, docteur ès sciences physiques)","doi":"10.1016/j.emcsto.2005.01.005","DOIUrl":null,"url":null,"abstract":"<div><p>The anti-inflammatory drugs belong to various chemical classes; they act in a purely symptomatic manner on the aspecific reaction of the tissues to an aggressive agent. The corticosteroid agents which are steroidal anti-inflammatory drugs have all a hormonal activity, concerning principally the metabolic regulations, and they cause pituitary-adrenal suppression. Some pathological states require particular attention but they are not necessarily contra-indicated for short duration prescriptions. Unerupted third molar extractions and oral dermatology are among their indications, with specific administration modalities. The non-steroidal anti-inflammatory drugs (NSAIDs) regroup various chemical classes but without any steroidal structure. The prostanoids biosynthesis inhibition by the NSAIDs is responsible for many of their pharmacological properties but also of their side-effects (essentially at the digestive, renal and cutaneous level). They can be prescribed in odontostomatology either for their analgesic properties, either for their anti-inflammatory and anti-oedematous properties, after careful analysis of the benefit/risk ratio. The new anti-inflammatory drugs (coxibs, selective inhibitors of the cyclo-oxygenase 2) have their main practical application in rheumatology, but they do not really provide notable advantages with regard to the incidence of side effects compared to conventional NSAIDs. Enzymes are anti-inflammatory drugs of modest efficiency, essentially used as anti-oedematous agents.</p></div>","PeriodicalId":100449,"journal":{"name":"EMC - Stomatologie","volume":"1 1","pages":"Pages 21-29"},"PeriodicalIF":0.0000,"publicationDate":"2005-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.emcsto.2005.01.005","citationCount":"9","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EMC - Stomatologie","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1769684405000098","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 9

Abstract

The anti-inflammatory drugs belong to various chemical classes; they act in a purely symptomatic manner on the aspecific reaction of the tissues to an aggressive agent. The corticosteroid agents which are steroidal anti-inflammatory drugs have all a hormonal activity, concerning principally the metabolic regulations, and they cause pituitary-adrenal suppression. Some pathological states require particular attention but they are not necessarily contra-indicated for short duration prescriptions. Unerupted third molar extractions and oral dermatology are among their indications, with specific administration modalities. The non-steroidal anti-inflammatory drugs (NSAIDs) regroup various chemical classes but without any steroidal structure. The prostanoids biosynthesis inhibition by the NSAIDs is responsible for many of their pharmacological properties but also of their side-effects (essentially at the digestive, renal and cutaneous level). They can be prescribed in odontostomatology either for their analgesic properties, either for their anti-inflammatory and anti-oedematous properties, after careful analysis of the benefit/risk ratio. The new anti-inflammatory drugs (coxibs, selective inhibitors of the cyclo-oxygenase 2) have their main practical application in rheumatology, but they do not really provide notable advantages with regard to the incidence of side effects compared to conventional NSAIDs. Enzymes are anti-inflammatory drugs of modest efficiency, essentially used as anti-oedematous agents.

炎症药物
抗炎药属于各种化学类别;它们以纯粹的症状方式作用于组织对攻击性试剂的特异性反应。皮质类固醇类抗炎药具有所有激素活性,主要涉及代谢调节,它们会引起垂体-肾上腺抑制。一些病理状态需要特别注意,但它们不一定是短期处方的禁忌。未中断的第三磨牙拔除和口腔皮肤科是它们的适应症之一,有特定的给药方式。非甾体抗炎药(NSAIDs)重组了各种化学类别,但没有任何甾体结构。非甾体抗炎药对前列腺素生物合成的抑制是其许多药理学特性的原因,但也是其副作用的原因(主要是在消化、肾脏和皮肤水平上)。在仔细分析收益/风险比后,它们可以在口腔医学中使用,因为它们具有镇痛特性,也可以具有抗炎和抗水肿特性。新的抗炎药(coxibs,环氧合酶2的选择性抑制剂)在风湿病中有其主要的实际应用,但与传统的非甾体抗炎药相比,它们在副作用发生率方面并没有真正提供显著的优势。酶是一种效率适中的抗炎药,主要用作抗水肿药物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信